Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Biden-Harris Administration expands access to sickle cell disease treatments
In a victory for people with sickle cell disease, the US government has announced a major step towards improving access to treatment.
Read more
Gilead expands access to PrEP HIV candidate in 120 countries
A new licensing agreement from Gilead Sciences and six generic drug manufacturers is poised to transform HIV prevention efforts
Genentech acquires Regor’s next-gen CKD inhibitor portfolio
Genentech has acquired Regor Pharmaceuticals’ next-generation CDK inhibitors for breast cancer treatment in a deal worth $850M.
Sanofi and Regeneron's allergy drug is first biologic for COPD
Sanofi and Regeneron have announced that dupilumab has received an FDA approval in COPD and an eosinophilic phenotype.
Novo Nordisk expands stem cell research arm with Evotec
Evotec has joined forces with Novo Nordisk to advance the clinical and commercial manufacturing of stem cell-based therapies.
US to donate 1 million mpox vaccines to Africa amid outbreak
In response to the ongoing mpox outbreak in parts of Africa, the US government has announced a significant donation of 1 million vaccines.
New ABPI Code of Practice includes updates from PMCPA
The 2024 edition of the ABPI’s Code of Practice was published today, including new procedures under the PMCPA.
GSK pursues co-administration of RSV and shingles vaccines
New findings have been revealed on the co-administration of GSK’s RSV and existing shingles vaccine.
Musk's vision implant gets FDA breakthrough device tag
Neuralink, Elon Musk’s brain-chip startup, has been given breakthrough device designation from the FDA for its experimental implant aimed at restoring vision.
Loading posts...
« Previous
1
…
3
4
5
6
7
…
18
Next »